Avenge Bio

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

Actym Therapeutics

This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Aura Biosciences

This biotechnology company develops virus-like drug conjugates to treat patients with solid tumours, specifically targeting ocular and bladder cancers.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.

KiraGen Bio

This biotechnology company develops gene-edited cell therapies to treat solid tumours for patients with glioblastoma and other cancers.